<DOC>
	<DOCNO>NCT01485198</DOCNO>
	<brief_summary>Patients osteoarthritis , degenerative joint disease , meet inclusion criterion allocate two group : - The control group receive Acetaminophen 750mg orally every 8 hour - The experimental group receive Autologous Hematopoietic Stem Cells bone marrow ( BMASC ) Signed informed consent require , well answer questionnaire . Patients experimental group receive subcutaneous G-CSF ( 10ug/kg/day ) 3 consecutive day , 4th day bone marrow harvest general sedation perform posterior iliac crest . The patient remain recovery room cell process Hematology Service Laboratory . Finally , BMASC infuse joint local anesthesia . The procedure ambulatory .</brief_summary>
	<brief_title>Autologous Stem Cells Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Patients knee osteoarthritis grade II III KellgrenLawrence radiographic scale Age &gt; 30 year Neurodegenerative , autoimmune , genetic psychiatric disease Active infection Recent joint infection Knee surgery history Knee joint fracture history</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>bone marrow</keyword>
	<keyword>G-CSF</keyword>
</DOC>